Sign in

CIK 0001211583

  • Non-accelerated filer
  • Smaller reporting company

FENNEC PHARMACEUTICALS INC.

Sign in to watch
Ticker
FENC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
British Columbia, Canada
Entity type
Operating
Phone
+1 919-636-4530
Business address
PO BOX 13628, 68 TW ALEXANDER DRIVE, RESEARCH TRIANGLE PARK, NC, 27709
Former names
ADHEREX TECHNOLOGIES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,550,718
in 5 filings, $1.4M under 10b5-1 plans

Net −$1,550,718. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 7 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-02-28 MANCHESTER MANAGEMENT PR, LLC 10% owner Sale −26,000 $9.26 $241K 166,666
2018-02-28 MANCHESTER MANAGEMENT PR, LLC 10% owner Sale −17,100 $9.41 $161K 2,183,397
2017-04-12 MANCHESTER MANAGEMENT PR, LLC 10% owner Sale −200 $3.45 $690 2,176,882
2017-04-12 MANCHESTER MANAGEMENT PR, LLC 10% owner Sale −200 $3.45 $690 1,650,999
2010-06-08 Southpoint Capital Advisors LP 10% owner Sale −41,504,000 200,000,000

Page 7 of 7 · 125 trades